The dopaminergic basis of sleep dysfunction and non motor symptoms of Parkinson's disease: Evidence from functional imaging
- 1 April 2009
- journal article
- editorial
- Published by Elsevier in Experimental Neurology
- Vol. 216 (2) , 247-248
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson's disease: An in vivo 11C-raclopride PET studyExperimental Neurology, 2008
- The metric properties of a novel non‐motor symptoms scale for Parkinson's disease: Results from an international pilot studyMovement Disorders, 2007
- Hypocretin (orexin) loss in Parkinson's diseaseBrain, 2007
- Pramipexole versus sertraline in the treatment of depression in Parkinson’s diseaseJournal of Neurology, 2006
- Non-motor symptoms of Parkinson's disease: diagnosis and managementThe Lancet Neurology, 2006
- Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic systemBrain, 2005
- The effects of pramipexole in REM sleep behavior disorderNeurology, 2003
- Factors impacting on quality of life in Parkinson's disease: Results from an international surveyMovement Disorders, 2002
- [ 11 C]raclopride and positron emission tomography in previously untreated patients with Parkinson's diseaseNeurology, 1994
- PET study on striatal dopamine D2 receptor changes during the progression of early parkinson's diseaseMovement Disorders, 1993